July 21, 2022

HER2-positive breast ASCC is exceptionally rare, its clinico pathological characteristics are insufficiently studied, and the im plications of neoadjuvant therapy, comprising targeted treatment against HER2. Here we reported that a 58-year-old woman with a histopathological diagnosis of HER2-positive ASCC gave a neo adjuvant therapy of albumin-paclitaxel, carboplatin in conjunction with trastuzumab every 3 weeks.

1.1. Study Objective: The study aims to review the current lit erature on sickle cell disease and dental implant as a treatment modality for the replacement of the missing dentition.

Porcelain veneers have long been a popular restorative option that have evolved into a well- accepted treatment that can be fabricated in various ways. Onlays are another common treatment modality used in contemporary dentistry to restore large areas of decay and to replace old restorations.